| Name | Induction Healthcare Group |
|---|---|
| Epic | INHC |
| Isin | GB00BJ0M3545 |
| Industry | Medical Equipment and Services |
| Latest share price | 8.50p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £7.85 | Debt ratio | n/a |
| Shares in issue | 92.38 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -56.73 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -3 | 52-week high / low | 7.00p / 19.30p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Induction Healthcare Group |
|---|---|
| Address | c/o Pinsent Masons, 30 Crown Place, Earl Street, London, United Kingdom, EC2A 4ES |
| Telephone | +44 (0)333 9398091 |
| Website | https://inductionhealthcare.com/ |
| Director | Position |
|---|---|
| Mr Paul Tambeau | CEO |
| Mr John McIntosh | CFO |
| Mr Christopher Samler | Executive Chairman |
| Mr Ian Johnson | Senior Independent Director |
| Mr Jane Elizabeth Silber | Independent Non-Executive Director |
| Mr Andrew Williams | Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/03/24 | 31/03/23 | 31/03/22 |
| Intangible asssets and goodwill | 21.43 | 25.94 | 40.72 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 21.93 | 26.5 | 42.5 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 3.76 | 2.67 | 4.59 |
| Cash and equivalents | 3.69 | 4.29 | 7.5 |
| Other current assets and asset held for resale | 3.99 | 4.88 | 0.79 |
| Total of all assets | 33.37 | 38.34 | 55.37 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 6.24 | 6.53 | 6.8 |
| Long term liabilities | 6.75 | 7.51 | 6.3 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 12.99 | 14.04 | 13.11 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 20.38 | 24.3 | 42.26 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.47 | 0.46 | 0.46 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -42.73 | -39.45 | -22.27 |
| Share premium account | 41.98 | 41.66 | 41.66 |
| Total equity | 20.38 | 24.3 | 42.26 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -4.2 | -17.39 | -9.13 |
| Pre-tax profit | -4.21 | -17.39 | -9.16 |